Сунитиниб Мсн

Сунитиниб Мсн is an oral medication used for certain types of cancer treatment. It belongs to the class of tyrosine kinase inhibitors, helping manage disease progression. This EU-sourced version is available for prescription-based therapy. Always consult a healthcare professional before use.

Сунитиниб Мсн is primarily used to treat specific cancers, including gastrointestinal stromal tumors (GIST) and advanced renal cell carcinoma (RCC). It may also be prescribed for pancreatic neuroendocrine tumors (pNET) under medical supervision. This medication works by targeting abnormal proteins in cancer cells to slow their growth. Patients often ask, 'what is Сунитиниб Мсн used for' to understand its role in treatment plans.

Common effects of Сунитиниб Мсн include fatigue, nausea, and digestive discomfort. Some users may experience skin discoloration or rashes as the body adjusts to the medication. These effects are typically temporary and vary by individual. Monitoring by a healthcare provider helps manage any persistent symptoms.

Store Сунитиниб Мсн in a cool, dry place away from direct sunlight. Keep the medication out of reach of children and pets. Avoid crushing or splitting tablets unless instructed by a healthcare professional. Report any unusual symptoms or side effects to your doctor promptly.

Сунитиниб Мсн may interact with certain medications, including strong CYP3A4 inhibitors or inducers. Grapefruit products can also affect its metabolism, so avoid consuming them while taking this drug. Alcohol use should be discussed with a healthcare provider to assess potential risks. Always inform your doctor about all medications and supplements you are taking.